About Cellbiome
Cellbiome offers products and services including Gut Microbiota Analysis and Probiotics Guidance.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Legal Name (주)쎌바이오텍인터내셔날
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Cellbiome
Cellbiome operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Cellbiome
Cellbiome offers a comprehensive portfolio of products and services, including Gut Microbiota Analysis and Probiotics Guidance.
Analysis of intestinal microorganisms is conducted using sequencing methods to assess diversity and health indicators
Guidance on probiotics selection is provided based on individual microbiota profiles to support health management
Similar companies to Cellbiome
10 companies that operate in the same segment as Cellbiome (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellbiome
Cellbiomes services are centered on the examination of intestinal microorganisms, where approximately 39 trillion microbes are found to reside in the human body, with 95 located in the digestive system. These microorganisms are known to maintain the immune system and influence various bodily functions. Through programs involving Next-Generation-Sequencing, balanced ratios of beneficial and harmful bacteria are analyzed to aid in health management strategies. Guides on probiotics and diets are offered to support personalized approaches, emphasizing the importance of microbial equilibrium for overall well-being.
Cellbiome offers Gut Microbiota Analysis and Probiotics Guidance.
Cellbiome operates through ,.